EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Digital phenotyping of CGM engagement reveals distinct glycemic outcomes

Bowen Zhang iD, Tomoki Okuno iD, Emma Li, Ethan Riggins, Evie L Shen, Joleen Vansomphone, Estelle M Everett, Gregory J Norman, Donald R Miller, Peter D Reaven, Hua Zhou, Jin J Zhou iD

PLOS Digital Health · 23.07.2026 · 5 (7) · e0001505

DOI: 10.1371/journal.pdig.0001505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Digital Health, online erschienen am 23.07.2026. Verfasst von Bowen Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of California, Los Angeles, California, United States of America. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHGRI NIH HHS, NIGMS NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benefits from continuous glucose monitors (CGMs) may depend on how devices are used over time—not only how often they are used. We linked one year of device-generated CGM wear data from 2,351 U.S. Veterans to electronic health records (EHRs) to characterize real-world usage during the first year after CGM initiation. To compare longitudinal use patterns in the presence of unsynchronized sensor replacement–related gaps and intermittent interruptions, we aligned daily wear streams using a complexity-adjusted, time-adaptive optimal transport (TAOT) distance and applied spectral clustering to identify data-driven usage phenotypes. To estimate the adjusted association between CGM usage phenotypes and clinical outcomes, we used a double/debiased machine learning framework to quantify 12-month changes in time in range ( Δ TIR) and mean glucose ( Δ MG). We identified three reproducible patterns of CGM usage: Consistent, Fluctuating, and Low engagement. Relative to Consistent wear, Fluctuating usage was associated with worse glycemic change ( Δ TIR = −3.56%, 95% CI: −4.76 to −2.36; Δ MG = +7.12 mg/dL, 95% CI: 4.91 to 9.32), and Low engagement showed larger deterioration ( Δ TIR = −7.00%, 95% CI: −10.80 to −3.14; Δ MG = +14.09 mg/dL, 95% CI: 6.52 to 21.67). Notably, 73.2% of Fluctuating users still met a common “adherence” threshold (≥80% days worn), indicating that simple coverage metrics can miss clinically relevant instability. The differences in glycemic change ( Δ TIR and Δ MG) between the Consistent and Fluctuating groups were most pronounced among subgroups with more intensive diabetes management needs, such as insulin pump or glucagon users, suggesting that sustained CGM usage may be particularly important when clinical management is more complex. Beyond CGM and diabetes, this work provides a generalizable framework for characterizing longitudinal usage patterns of intermittently used digital health technologies and linking derived usage phenotypes to clinical outcomes. The approach can support more precise evaluation, monitoring, and intervention design for a wide range of real-world digital health tools.

Autor:innen und Institutionen

  • Department of Biostatistics, University of California, Los Angeles, California, United States of America.
  • Phoenix VA Health Care System (111E), Phoenix, Arizona, United States of America.
  • Castilleja School, Palo Alto, California, United States of America.
  • Department of Mathematics, University of California, Berkeley, California, United States of America.
  • Union County Magnet High School, Scotch Plains, New Jersey, United States of America.
  • Huntington Beach High School, Huntington Beach, California, United States of America.

ORCID-Profile: Bowen Zhang, Tomoki Okuno, Jin J Zhou

Förderung

  • NIDDK NIH HHS
  • NHGRI NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Science Foundation

Zitieren

APA

Zhang, B., Okuno, T., Li, E., Riggins, E., Shen, E. L., Vansomphone, J., Everett, E. M., Norman, G. J., Miller, D. R., Reaven, P. D., Zhou, H., & Zhou, J. J. (2026). Digital phenotyping of CGM engagement reveals distinct glycemic outcomes. PLOS Digital Health, 5(7), e0001505. https://doi.org/10.1371/journal.pdig.0001505

Vancouver

Zhang B, Okuno T, Li E, Riggins E, Shen EL, Vansomphone J, et al. Digital phenotyping of CGM engagement reveals distinct glycemic outcomes. PLOS Digital Health. 2026;5(7):e0001505. doi:10.1371/journal.pdig.0001505

BibTeX
@article{Zhang2026,
  author = {Zhang, Bowen and Okuno, Tomoki and Li, Emma and Riggins, Ethan and Shen, Evie L and Vansomphone, Joleen and Everett, Estelle M and Norman, Gregory J and Miller, Donald R and Reaven, Peter D and Zhou, Hua and Zhou, Jin J},
  title = {Digital phenotyping of CGM engagement reveals distinct glycemic outcomes},
  journal = {PLOS Digital Health},
  year = {2026},
  volume = {5},
  number = {7},
  pages = {e0001505},
  doi = {10.1371/journal.pdig.0001505}
}
Kostenlos starten →